Stefano Ferrari Selected Research

Thrombocytopenia (Thrombopenia)

10/2018	Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
1/2017	Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Ferrari Research Topics

Disease

67	Neoplasms (Cancer) 11/2022 - 01/2002
58	Osteosarcoma (Osteogenic Sarcoma) 11/2023 - 01/2002
29	Sarcoma (Soft Tissue Sarcoma) 11/2023 - 07/2003
22	Ewing Sarcoma (Sarcoma, Ewing) 06/2021 - 02/2003
20	Neoplasm Metastasis (Metastasis) 06/2021 - 01/2002
18	Necrosis 01/2022 - 01/2002
12	Endometriosis 01/2023 - 03/2009
6	Disease Progression 01/2019 - 12/2005
5	Margins of Excision 12/2016 - 01/2004
4	Wounds and Injuries (Trauma) 01/2023 - 05/2006
4	Ectrodactyly-cleft lip-palate syndrome 01/2023 - 01/2012
4	Limbal Stem Cell Deficiency 11/2018 - 07/2010
4	Giant Cell Tumor of Bone 10/2018 - 09/2015
4	Inflammation (Inflammations) 05/2017 - 09/2004
4	Pain (Aches) 02/2017 - 04/2012
4	Synovial Sarcoma (Synovioma) 01/2017 - 01/2014
3	Keratoconus 12/2023 - 06/2013
3	Fuchs' Endothelial Dystrophy 02/2023 - 10/2021
3	Burns 12/2022 - 11/2018
3	COVID-19 11/2022 - 01/2022
3	Cysts 01/2022 - 05/2020
3	Chondrosarcoma 01/2021 - 02/2011
3	Hypertension (High Blood Pressure) 01/2019 - 02/2002
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2018 - 06/2014
3	Neutropenia 10/2018 - 07/2003
3	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 12/2008 - 05/2006
3	Second Primary Neoplasms (Neoplasms, Second) 12/2006 - 01/2004
2	Dehydration (Water Stress) 12/2023 - 04/2019
2	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 05/2020
2	Genomic Instability 01/2019 - 12/2010
2	Extraskeletal Myxoid Chondrosarcoma 01/2019 - 12/2013
2	Thrombocytopenia (Thrombopenia) 10/2018 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 07/2007
2	Spontaneous Fractures (Pathological Fracture) 10/2016 - 08/2003
2	Ectodermal Dysplasia (Aplasia Cutis Congenita) 08/2016 - 01/2012
2	Ectrodactyly 08/2016 - 01/2012
2	Blindness (Hysterical Blindness) 02/2016 - 01/2016
2	Breast Neoplasms (Breast Cancer) 02/2014 - 10/2012
2	Mucositis 06/2013 - 07/2003
2	Prostatic Neoplasms (Prostate Cancer) 05/2013 - 01/2003

Drug/Important Bio-Agent (IBA)

15	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 11/2003
14	Ifosfamide FDA LinkGeneric 01/2022 - 11/2003
13	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 11/2003
12	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 07/2003
6	Denosumab FDA Link 06/2022 - 08/2013
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2005
6	Alkaline PhosphataseIBA 02/2017 - 01/2002
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 02/2003
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2017 - 09/2004
4	AnthracyclinesIBA 01/2022 - 12/2013
4	TrabectedinIBA 01/2022 - 01/2017
4	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 03/2010
4	Phosphotransferases (Kinase)IBA 01/2015 - 06/2004
4	Sorafenib (BAY 43-9006)FDA Link 01/2015 - 12/2009
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2022 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 06/2022 - 12/2003
3	Busulfan (Busulfex)FDA Link 06/2021 - 06/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2010
3	Insulin-Like PeptidesIBA 01/2018 - 05/2011
3	Messenger RNA (mRNA)IBA 01/2018 - 12/2008
3	ezrinIBA 01/2015 - 04/2008
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2012
2	Trypan Blue FDA Link 01/2023 - 01/2019
2	Photosensitizing Agents (Photosensitizers)IBA 08/2022 - 05/2015
2	mifamurtideIBA 06/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Melphalan (Alkeran)FDA LinkGeneric 06/2021 - 01/2018
2	Indicators and Reagents (Reagents)IBA 05/2020 - 01/2010
2	Retinaldehyde (Retinal)IBA 05/2020 - 06/2012
2	diphenyl (biphenyl)IBA 04/2020 - 01/2020
2	LigandsIBA 01/2020 - 01/2013
2	pazopanib FDA Link 01/2019 - 07/2014
2	Alanine Transaminase (SGPT)IBA 01/2019 - 10/2018
2	RheniumIBA 12/2018 - 03/2014
2	Oral ContraceptivesIBA 01/2018 - 06/2012
2	Carrier Proteins (Binding Protein)IBA 01/2018 - 01/2010
2	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 11/2015
2	Peptides (Polypeptides)IBA 10/2016 - 08/2005
2	ProdrugsIBA 10/2015 - 03/2014
2	Everolimus FDA Link 01/2015 - 04/2013
2	Cytidine Diphosphate (CDP)IBA 11/2014 - 06/2012
2	Metformin (Glucophage)FDA LinkGeneric 01/2014 - 01/2013

Therapy/Procedure

71	Drug Therapy (Chemotherapy) 11/2023 - 01/2002
29	Therapeutics 11/2023 - 02/2002
27	Neoadjuvant Therapy 06/2021 - 01/2002
16	Radiotherapy 01/2020 - 01/2004
9	Corneal Transplantation (Keratoplasty) 12/2023 - 04/2012
7	Transplantation 11/2022 - 12/2006
6	Laser Therapy (Surgery, Laser) 01/2023 - 03/2009
5	Cystectomy 01/2023 - 10/2019
5	Surgical Amputation (Amputations) 01/2020 - 08/2003
5	Adjuvant Chemotherapy 09/2016 - 10/2010
4	Lasers (Laser) 01/2022 - 05/2020
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 05/2006
3	Gas Lasers 01/2022 - 12/2020
3	Stem Cell Transplantation 06/2021 - 05/2003
3	Limb Salvage 08/2007 - 08/2003
2	Operative Surgical Procedures 01/2018 - 05/2006
2	Aftercare (After-Treatment) 09/2017 - 02/2017
2	Adjuvant Radiotherapy 06/2017 - 11/2009